Summary
Intuitive Surgical, Inc. (ISRG) reported strong growth in its second quarter and first half of 2011, with total revenue increasing by 21% and 19.8% year-over-year, respectively. This growth was primarily driven by robust performance in both system sales and recurring revenue from instruments, accessories, and services. The company saw a significant increase in the number of da Vinci Surgical Systems sold and procedures performed, indicating continued market adoption of their advanced surgical technology. Profitability also improved, with net income rising significantly, reflecting effective cost management and a growing contribution from higher-margin recurring revenue streams. The company's financial position remains strong, with substantial cash, cash equivalents, and investments providing ample liquidity for future operations and growth initiatives. Key strategic initiatives such as the introduction of new da Vinci models (Si-e), the da Vinci Skills Simulator, and innovative instruments like da Vinci Single-Site and Fluorescence Imaging are contributing to market expansion and deeper penetration into various surgical specialties. While the company faces ongoing litigation and potential market risks, its solid financial performance, strong installed base, and commitment to innovation position it well for continued success in the expanding field of robotic-assisted surgery. Investors should note the increasing percentage of recurring revenue, which offers a more predictable and potentially higher-margin income stream.
Financial Highlights
48 data points| Revenue | $425.70M |
| Cost of Revenue | $119.10M |
| Gross Profit | $306.60M |
| R&D Expenses | $32.00M |
| SG&A Expenses | $106.50M |
| Operating Expenses | $138.50M |
| Operating Income | $168.10M |
| Net Income | $117.40M |
| EPS (Basic) | $0.33 |
| EPS (Diluted) | $0.32 |
| Shares Outstanding (Basic) | 352.80M |
| Shares Outstanding (Diluted) | 362.70M |
Key Highlights
- 1Total revenue for the three months ended June 30, 2011, increased 21% to $425.7 million from $350.7 million in the prior year period.
- 2Da Vinci procedures performed increased approximately 30% year-over-year for the quarter, signaling strong adoption.
- 3Instruments and accessories revenue grew 35% to $171.5 million, and service revenue increased 22% to $67.6 million, highlighting the growing importance of recurring revenue streams.
- 4The company sold 129 da Vinci Surgical Systems in the quarter, up from 108 in the same period last year, with 94% being the newer da Vinci Si models.
- 5Net income for the quarter rose to $117.4 million, or $2.91 per diluted share, compared to $88.7 million, or $2.19 per diluted share, in the prior year.
- 6The installed base of da Vinci Surgical Systems grew to 1,933 as of June 30, 2011.
- 7The company's cash, cash equivalents, and investments increased to $1.82 billion, demonstrating a strong liquidity position.